• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign

Posted on: Thursday, 2 July 2009, 09:00 CDT

LUMBY, BC, July 2 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the engagement of Koeppel Direct to manage their direct response media buying.

Lorie Campbell-Farley, President/COO of avVaa World Health Care is excited to be associated with Koeppel Direct, a world-class direct response television media buying agency, specializing in Multi-Channel Direct Response Television - DRTV online direct response, radio direct response and print direct response campaign management. Koeppel Direct has a reputation for generating increased results, immediately and over the long-term.

Loren Wayne of Koeppel Direct states his firm is leading the charge to provide clients in the direct response industry with an integrated, multi-channel response media buying strategy. "We will integrate all the key mediums that comprise an effective direct response media buy, including-direct response television (DRTV), online, print, and radio to ensure the success of the avVaa World Health Care direct response media campaign".

Ms Farley, states, "it's a wonderful feeling that Koeppel Direct knows the ins and outs of maximizing the impact of a direct response television advertizing campaign. The caliber of Koeppel Direct's direct response media buying performance is why marketers depend on their expertise campaign after campaign."

avVaa World Health Care will receive DRTV media buying results that are measurable specific and immediate.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(r) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

SOURCE avVaa World Health Care Products

Source: PR Newswire

More News in this Category